US Patent Issued to IO Biotech on Feb. 17 for "Vaccine compositions comprising C-C motif chemokine 22 (CCL22) or fragments thereof" (Danish Inventor)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,543, issued on Feb. 17, was assigned to IO Biotech ApS (Copenhagen N, Denmark).

"Vaccine compositions comprising C-C motif chemokine 22 (CCL22) or fragments thereof" was invented by Mads Hald Andersen (Naerum, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to CCL22 as a T cell target in cancer immunosuppression."

The patent was filed on March 10, 2022, under Application No. 17/691,468.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12551543&O...